FOLH1 and nonpapillary renal cell carcinoma: Furthermore, according to the meta-analysis by Singhal et al. from 2024, including 11 papers published between 2015 and 2023, PSMA PET/CT scans had a pooled sensitivity for ccRCC of 94.7% (95% CI: 88–98.3%) in the “per patient” analysis and a pooled sensitivity of 91.0% (95% CI: 86.4–94.4) in the “per lesion” analysis [71].